← Leaderboards
Fang Liu
Zymeron Corporation
$900,000
Attributed
$900,000
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $600K · FY2020–21$1M$750K$500K$250K$0
'20
'21
Funding mix
By agency
NIH$900,000 · 3
By mechanism
N43$900,000 · 3
Top collaborators
No co-investigators on record.
Most similar at Zymeron Corporation
Same institution · by research overlap
- Xu Li$599,998
- Zhiguo Zhou$1,198,791
Others in their field
Other Emerging Leaders on “Nucleic Acids”
- Leonard Freedman · Leidos Biomedical Research, Inc.$51,996,524
- Bala Raja · Luminostics, Inc.$28,624,460
- Lynn Briscoe · Leidos Biomedical Research, Inc.$25,343,101
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Dave Beebe · Flambeau Diagnostics Llc$16,670,000
- Robert J Woods · Virginia Polytechnic Institute And State University$12,760,318
Research focus
Nucleic AcidsTherapeutic DevelopmentAntiviral AgentsDesignAntigensAntigen TargetingAttentionBaseBindingCell ModelChronic Hepatitis BContractsCytokineCytotoxicityDrug DevelopmentEncapsulatedEnv Gene ProductsGranulocyte-Macrophage Colony-Stimulating FactorHepatitis B VirusHiv-1Hiv VaccineHydrogelsInjectableLibraries
Grant awards (3)
Small Molecule Degraders of Intracellular HIV Proteins as Novel Anti-HIV Therapeutics$300,000
N43 · FY2021 · AI · contact PI
Novel Nanoparticle-in-Hydrogel Co-delivery of Adjuvanted saRNA as HIV Vaccine$300,000
N43 · FY2020 · AI · contact PI
ANTIVIRAL DRUG DEVELOPMENT FOR CHRONIC HEPATITIS B VIRUS INFECTION$300,000
N43 · FY2020 · AI · contact PI